Isolagen Inc filed for Chapter 11 bankruptcy protection last week. The biotechnology company is developing a therapy to treat wrinkles and skin conditions and is continuing to operate as a debtor in possession.
The company is borrowing $2.75 million for general corporate purposes. Final approval of the company’s financing proposal will be decided at a hearing on July 6. Isolagen Inc will then continue with the bankruptcy process.
If you are consdering bankruptcy, contact the Boston bankruptcy attorneys of Joshua Spirn & Associates at 800-975-5346.
